We are building the computational infrastructure to generate high-fidelity digital twins for clinical and pharmaceutical R&D.
While our full simulation engine is in active development, we believe in open collaboration. Our first foundational tool is now live: an AI-driven, natural-language workspace to help researchers build the workflows that will power tomorrow's digital twins.
Building a digital twin requires immense computational scaffolding. We are opening our internal AI-driven chat workspace to the community—allowing researchers to execute complex bioinformatics pipelines using natural language.
Profile PT-8924 loaded. I've computed the baseline trajectory. Here is the UMAP projection:
Target throughput for the VECTR-Match simulation environment.
Simulated per digital twin to guarantee theoretical hemodynamic safety.
Expected acceleration from hypothesis to phase I clinical trial design.
The continuous pipeline we are actively building to bridge the atomic scale to frontline patient care.
High-throughput molecular simulation to validate ligand binding prior to chemical synthesis. Designed to accelerate discovery pipelines by orders of magnitude.
Translating atomic interactions into physiological pathways. Designed to visualize cascading biological effects to ensure immunological stability.
The ultimate test. Forecasting hemodynamic stability within chaotic clinical scenarios to theoretically guarantee safety prior to patient administration.
Internal use-cases currently driving the development of the E.sapiens engine.
Lab findings often fail in human trials because of the ICU "Day 0" observation gap. By the time a patient is admitted and observed, the critical biological window has passed.
We are developing methodologies to apply Dynamic Time Warping (DTW) to time-series RNA-seq data. By clustering temporal trajectory archetypes, we aim to reconstruct the pre-admission biological window.
Traditional oncology relies on a stochastic 'cell-kill' model, often leading to therapy resistance. Project RE-MAP is researching a transition to a deterministic state-steering paradigm.
By mapping single-cell RNA velocity, our future VECTR-Match engine is designed to screen perturbation profiles to actively steer Glioblastoma stem cells into stable differentiation valleys.
We are actively building the full E.sapiens pipeline alongside leading pharmaceutical research groups and clinical directors.
While the interactive workspace is live today, our full simulation engine is currently in a closed, private beta. Submit an inquiry to join the waitlist and discuss potential computational partnerships.